What an HPV Diagnosis Really Means
For starters, it does not mean you have cancer—or that you’re destined to develop it.
Related Articles
Radiation-Associated Secondary Cancer in Patients With Breast Cancer
This cohort study examines the risk of radiation-associated sarcoma in patients with breast cancer harboring germline TP53 variants.
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer
Three-dimensional invasion-linked gene expression analysis reveals a therapeutic vulnerability to inhibition of ALK2/BMP6 signaling in LKB1-mutant lung cancer that can be rapidly translated to the…
Should There Be Better Guidelines for Managing Fear of… : Oncology Times
An abstract is unavailable.
Menin inhibitors emerge as new treatment for advanced AML – The Cancer Letter
The world of cancer treatments continues to evolve, and for those diagnosed with blood cancers, a new option can be found in menin inhibitors—the latest…
Paltusotine May Address Unmet Need in NETs Patients With Carcinoid Syndrome
Paltusotine can alleviate symptoms of carcinoid syndrome in patients with neuroendocrine tumors, a phase 2 study suggests.
Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN
Mirdametinib led to sustained, significant, and clinically meaningful improvements in HRQOL in adults and children with NF1-PN.
Program: Wednesday, February 26
wednesday, february 26 continental breakfast 7-8 a.m. Keynote Session 4 8-8:30 a.m. Session Chair: Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California education…
Enhancing ctDNA monitoring for prime time use in high-risk melanoma
Meghan Mooradian, MD, Massachusetts General Hospital, Boston, MA, reviews how current research can improve circulating tumor DNA (ctDNA) monitoring before prime time use for patients…
The Targeted Pulse: Discover Key FDA Actions in Leukemia and NSCLC and The Significant Effects of TKIs in CML and CLL
The FDA grants approval to revumenib (SNDX-5613) for a subgroup of acute leukemia, and dato-dXd moves into the final stage in NSCLC. We also cover…
